End-To-End Cell and Gene Therapy Solutions

​​​We share your mission to develop life-changing cell and gene therapies. Accelerate commercialization with end-to-end solutions that deliver reproducible performance and scalability with a simplified path to regulatory approvals.

​From discovery, to process development, to clinical and commercial manufacturing, our portfolio of proven solutions helps you achieve faster time-to-market while saving costs. Together, we're setting the standard in cell and gene therapy.

Consult Our Experts Request Your Sample

Sartorius Event

Sartorius Cell & Gene Therapy Forum, Boston, MA, October 23, 2025

Join us in Boston on October 23 for the Sartorius Cell & Gene Therapy Forum. Register now to secure your early-bird rate and connect with the experts shaping the future of cell and gene therapies.

Buy Ticket Here
eBook

Cell & Gene Therapy in Conversation: Q&A With Seven Experts

Discover how experts view the evolving CGT landscape, and what’s needed to advance it forward.

Setting the Standard in Cell and Gene Therapy, Together

Performance

Setting the Standard in Reproducible Performance
A high-performing process lays the foundation for reproducible results. Accelerate your cell and gene therapy development with high-throughput technologies that promote process efficiency, optimized critical raw materials that improve yield, and intuitive data analytics that inform decision-making.

Scalability

Setting the Standard in Streamlined Scale-Up
Designed with scalability in mind, our range of cell culture bioreactors, single-use bags, media, and reagents enable seamless process transfer to larger volumes. Streamline revalidation and optimization from the start by leveraging decades of demonstrated expertise in scalable upstream and downstream solutions.

Regulatory Compliance

Setting the Standard for a Simplified Path to Regulatory Compliance
In a rapidly changing landscape, adhering to the latest regulatory requirements is critical to simplifying your registrations and interactions with authorities. Meet efficacy and safety standards with products and services backed by rigorous quality-assurance processes and trusted to deliver approved therapeutics worldwide.

Leverage Decades of Experience in Cell and Gene Therapy 

Trusted Expertise

30+

Years of technical and regulatory expertise in cell and gene therapy and medicine
icon-thinking

Globally Proven Solutions

15+

FDA- and EMA-approved therapies use our dedicated cell and gene therapy solutions
icon-regulatory-stamp

Find the Right Solution

Simplify Your Research, Development, and Manufacturing Workflows

Immune Cell Therapy

Empower your immune cell therapy process with solutions driven by reproducibility, scalability, and quality.

Stem Cell Therapy

Support each step of MSC, iPSC, and HSC workflows from discovery to commercialization.

AAV Gene Therapy

Accelerate your AAV workflow with robust, scalable, and high-quality consumables, technologies, and services. 

Lentivirus Gene Therapy

Empower your lentivirus gene therapy process with solutions driven by performance, scalability, and quality.

Cell Therapy 

Simplify the route of your cell therapy from discovery, to development, and on to manufacturing.

Gene Therapy

Browse technologies, analytics, and services that support your gene therapy toward commercialization.

More About CGT From Sartorius

See How Sartorius Drives Your Success in Cell & Gene Therapy

Ready to set the standard in cell and gene therapy with Sartorius? Watch our teaser video to see how we’re helping to make the impossible possible — with our innovative technologies, expert support, and more.

White Paper

Perspectives on Performance, Scalability & Regulatory Compliance

This whitepaper offers expert insights on accelerating commercialization with solutions that enhance performance and streamline approvals.

Download White Paper

Related Assets for Cell and Gene Therapy

Webinar

Enabling a Robust AAV Upstream Platform Using Next-Gen Raw Materials

In collaboration with Nantes University, this webinar will demonstrate an upstream AAV platform made with a DOE approach.

White Paper

Optimized Aliquoting for Robust Cell and Gene Therapy Processes

Read about the challenges of liquid handling in CGT processes, and how new solutions can simplify aliquoting. 

Webinar

Assessing E&Ls from Single-Use Systems Used in ATMP Production

Expert Talk: How do single-use systems affect therapeutic cells? 

Webinar

Advancing Cardiac Medicine With High-Quality Raw Materials

Learn how high-quality raw materials simplify the journey of cardiomyocyte therapies from lab to clinical trials.

eBook

Finding the Right Cell Culture Media for Your Bioprocesses

Enhance your cell culture media strategy for protein, viral, and cell-based production processes. 

Blog

Assessing Extractables & Leachables From Single-Use Systems

See how the differences between CGT and traditional biopharmaceutical manufacturing are giving rise to new risk assessment challenges.

Webinar

Optimizing Perfusion Parameters for CAR-T Cells

Discover methods for growing and enhancing CAR-T cells in automated stirred-bioreactors.

Poster

Mitigating Virus Risk in Viral Vector & Gene Therapy Culture Media

Reach therapeutic doses of CAR-T cell therapy with scalable expansion processes. 

Poster

Mitigating Virus Risk in Viral Vector & Gene Therapy Culture Media

Control virus risk in cell culture media for viral vector and gene therapy.

Article

Mitigating Cell Culture Variability With Robust Screening

Learn how to mitigate cell culture variability with robust screening of raw materials and adhere to GMP guidelines.

End-to-End Solutions for Your Workflow

Explore Our Cell and Gene Therapy Product Portfolio

Browse our featured products below to find solutions that shorten your time-to-market and improve cost-efficiency at every step of your workflow.

Featured Products & Services

Accelerate Your Advanced Therapy Development

Optimize your cell and gene therapy process with expert development support—from early stages to scale-up—for efficiency, consistency, and compliance.

Transfection Reagents and pDNA

Increase AAV titer and particle quality with optimized transfection reagents and plasmids. 

Counterflow Centrifugation: GMP-Ready, Scalable Cell Harvesting

Ksep® empowers next-generation cell therapies with gentle, single-use automated centrifugation technology.

Celsius® FFT Freezing Solution

Manage your entire cold chain with confidence – from filling and freezing to shipping, thawing, and dispensing.

Recombumin® Recombinant Human Albumin

Stabilize your cell and gene therapy product with versatile recombinant human albumin.

Sartoclear® Depth Filters

Remove turbidity, increase AAV yield, and scale up easily with high-capacity and low-adsorption filters. 

Biowelder® S Automated Aseptic Welder

Automated aseptic welder for PVC & TPE tubing, streamlining processes in GMP manufacturing and CGT.

Biostat STR® With DeltaV® Control System

Achieve higher viability and yield from 200 to 2,000 liters with geometrically consistent bioreactor vessels. 

TFF Cassettes

Increase viral vector recovery using low adsorption membranes with MWCO ranging 30 to 300kDa, available in closed, presterilized units.

Flexsafe® 2D Bags

Protect your product during storage and shipping for sterile filtration, media preparation, sampling, and fluid transfer steps.

icon-multiple-choice

Request Your Sample | Raw Materials and Consumables

To help find the right materials and consumables for your needs, request a sample from our portfolio.

Request Your Sample

FAQs - Cell and Gene Therapy

Cell therapy uses cells grown ex vivo as treatment. There are two main types — regenerative medicine, where cells or organs are produced for replacement, and gene-modified cell therapy (ex vivo gene therapy), where cells are modified to target disease. Gene therapy is designed to correct, suppress, or insert genes within cells to treat or prevent diseases like cancer and genetic disorders. In vivo gene therapy directly delivers the gene to the patient's body.

Read Now

Gene therapy can be used for in vivo treatment, where the treatment is injected directly into the patient. In ex vivo treatment, also known as gene-modified cell therapy, the cells are extracted, modified, and then reinjected into the patient. Cell therapy terminology is often used as gene-modified therapies, using cells for treatment. Cells like stem cells and induced pluripotent stem cells can be used for this purpose, as well as for regenerative medicine.
 

Scientists prefer single-use equipment to mitigate the risk of cross-contamination as well as contamination from viruses and bacteria. In cell therapy, scientists don't perform filtration or chromatography because the cells are the final product. However, a bioreactor and centrifuge are needed to separate, clean, and wash the cells. If you're using a viral vector for gene therapy, you'll also need a bioreactor, along with a complete downstream process including standard filtration, tangential flow filtration, and chromatography.

Continued Commitment to CGT Excellence

News & Events

Learn more about cell and gene therapy news and events.

Sartorius Event

Sartorius Cell & Gene Therapy Forum, Boston, MA, October 23, 2025

Join us in Boston on October 23 for the Sartorius Cell & Gene Therapy Forum. Register now to secure your early-bird rate and connect with the expe...

Events

Visit Us at ESGCT Spain: Explore Our Cell & Gene Therapy Solutions

Join us in Seville, Oct 7-10, for talks, product exhibitions, and learn how to accelerate commercialization with our solutions.

Sartorius Event

Virtual Event | AAV — Stirred, Not Shaken

Get a taste of the latest developments in AAV gene therapy manufacturing and stir things up with a mocktail-making session. 

Webinar

Inside the Development of an AAV8 Production Platform

Watch our on-demand webinar in collaboration with CDMO Matica Biotechnologies, where we'll showcase a scalable AAV8 production process.   

Webinar

Building Reliability Into AAV Scale-Up

Watch our webinar to learn about scalable platforms and their benefits throughout an AAV product’s lifecycle.

Webinar

Support high-performing, scalable AAV purification

Watch our webinar with iBET and learn how to establish a scalable platform for multiple AAV serotypes from PD to manufacturing.

Webinar

Maximizing CAR-T Cell Yields

Learn how CAR-T process intensification can support higher cell densities, enabling seamless scale-up and reducing process development costs.

Press Release

Polyplus, now part of Sartorius

July 18, 2023 - Sartorius completes acquisition of Polyplus

Press Release

New CGT Center in Freiburg (Germany)

September 19, 2023 - Sartorius establishes a competence center for manufacturing components for cell and gene therapies in Freiburg 

Press Release

Forming Partnerships

September 28, 2023 - Sartorius forms partnership with SPARTA Biodiscovery on novel nanoparticle analysis platform

Press Release

Albumedix, now part of Sartorius

September 30, 2022 - Sartorius completes acquisition of Albumedix

Webinar

Enabling a Robust AAV Upstream Platform Using Next-Gen Raw Materials

In collaboration with Nantes University, this webinar will demonstrate an upstream AAV platform made with a DOE approach.

Webinar

The Journey to Liter-Scale CAR-T Cell Production with Perfusion

Watch our webinar with experts from UCL and Repligen, where we’ll showcase seamless scale-up of a CAR-T perfusion process. 

Consult Our Experts

Consult Our Cell and Gene Therapy Experts